HIV-IT Direct Vector Study Schedule 
' 
CJ v 
§ . 
S3 £■ 
3 i 
*3 1 ' 
Wo 
— r 
s 
*s 
U* " 
' \ 
m 
m 
m 
VO 
CO 
X 
X 
X 
X 
X 
X 
X 
X 
o 
CO 
X 
X 
X 
X 
3 
X 
X 
X 
X 
X 
X 
X 
X 
00 
rH 
X 
X 
X 
X 
X 
rH 
X 
X 
X 
X 
X 
X 
X 
X 
X 
VO 
X 
X 
X 
X 
X 
X 
X 
X 
>» 
|§ 
s 
X 
X 
o 
r- 
X 
X 
X 
X 
X 
X 
X 
X 
Treatment 
s 
if 
Q 
VO 
•o 
cn 
co 
to 
X 
X 
X 
X 
X 
X 
X 
VO 
CO 
X 
X 
00 
cs 
£ 
3 
X 
X 
X 
X 
X 
X 
X 
c* 
X 
X 
o 
=tfc 
\ > Baseline \ 
Tf 
1 
X 
X 
X 
X 
X 
X 
X 
X 
00 
H 
« 
X 
CO 
CO 
• 
X 
X 
X 
X 
X 
O 
CT\ 
• 
X 
X 
X 
X 
X 
X 
X 
X 
History and Physical 
DTHT 
CTL Targets 
Clinical Labs 
Lymphocyte Subsets 
HIV-1 Antibodies 
Viral Load 
CTL Assay 
Other Potential 
Surrogate Markers 
PCR/Neo 
Injections 
[914] 
Recombinant DNA Research, Volume 17 
